Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives.

In a recent clinical trial, after the administration of chitosan oligosaccharide (GO2KA1, a code name of chitosan oligosaccharide), it showed a decreasing trend in body fat ratios and waist circumferences, serum glucose levels, HbA1c (Hemoglobin A1c, a subtype of glycosylated hemoglobin), and C peptides (a byproduct in the formation of insulin) [ 89 ].

also in 47,180 other papers

Similarly, an increasing trend of the population of Akkermansia muciniphila was also found in atorvastatin-treated hypertension patients [ 48 ].

also in 63,971 other papers